International Neuromodulation Society Congress

Information About Attending the INS 13th World Congress

May 27 - June 1, 2017 in Edinburgh, Scotland

Continuing Medical Education

Registered delegates will receive instructions via email from Wiley / Blackwell Futura for claiming CME credit. Delegates wishing to receive a CME or attendance certificate must complete a course and session evaluation form on Wiley’s Health Learning platform. For assistance with logging in to the evaluation system and printing a certificate, please contact Wiley at [email protected].

European Accreditation
The 'International Neuromodulation Society' (or) 'International Neuromodulation Society 13th World Congress. Neuromodulation: Technology Changing Lives' is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS), www.uems.net.

The 'International Neuromodulation Society 13th World Congress. Neuromodulation: Technology Changing Lives' is designated for a maximum of (or 'for up to') 25 hours of European external CME credits. Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

Through an agreement between the European Union of Medical Specialists and the American Medical Association, physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 Credits^TM. Information on the process to convert EACCME credit to AMA credit can be found at www.ama-assn.org/go/internationalcme.

Live educational activities, occurring outside of Canada, recognized by the UEMS-EACCME for ECMEC credits are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of The Royal College of Physicians and Surgeons of Canada.

U.S. Accreditation and Designation
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Blackwell Futura Media Services and the International Neuromodulation Society. Blackwell Futura Media Services is accredited by the ACCME to provide continuing medical education for physicians.
 
Blackwell Futura Media Services designates this CME Live Activity for a maximum of 41 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

United Kingdom CPD Credits

This event is approved by the Royal College of Anaesthetists for 20 CPD credits.

INS Congress Learning Objectives

Following completion of the activity, participants will be better able to:

1. Discuss new scientific data and clinical guidelines to improve patient selection and treatment outcomes for neuromodulation.

2. Identify potential benefits, limitations and complications of neuromodulation therapies.

3. Interpret study results based on trial design and apply lessons learned for application in the design of future trials.

4. Analyze and understand psychiatric factors affecting outcomes in the treatment of chronic pain, movement disorders, cognitive and other disorders.

5. Describe the bioengineering challenges and solutions at the neural interface, fundamentals and mechanisms of action of neuromodulation.

6. Discuss and analyze the anatomy and physiology of the central CNS, peripheral and autonomic nervous systems to assist in patient selection, target selection and likelihood of therapeutic success.

7. Discuss the uses of devices for functional electrical stimulation including rehabilitation of motor loss, loss of sensory function, and loss of cognitive function.

8. Describe emerging neuromodulation therapies, new paradigms of therapy target selection and associated research in the medical field of neuromodulation.

9. Distinguish mechanisms of disease states, such as complex regional pain syndrome, refractory angina and visceral pain syndromes and explain the current position of neuromodulation in these conditions.

10. Explain the many variations now available for electrical stimulation and how to select the appropriate technology.

11. Describe the increasing application of neuromodulation for chronic heart disease, as well as genitourinary and gastrointestinal disorders.

12. Explain the scientific merit and best practices for the use of intrathecal drug infusions including patient selection, drug selection and complication management.

13. Critically appraise research methodology in neuromodulation and recognize how evolving treatment guidelines and registries are important.

14. Apply the increasing knowledge base for neuromodulation in a wide variety of chronic illness management.

15.  Explain how cancer pain management has evolved into managing the pain of cancer survivors and recognize the growing need for neuromodulation solutions.

16. Increased knowledge on basic mechanisms for neural plasticity that can be induced by novel vagus nerve stimulation paradigms.

CME Mission Statement

The International Neuromodulation Society promotes improvement in patient health care by providing physicians and allied health care professionals with high quality, evidence-based educational activities focusing on advances in the field of neuromodulation; basic, translational and clinical research; new technology; and global health care. The overarching goals are to enhance learners’ knowledge, competence and performance to improve patient access, selection, safety and clinical outcomes.

Venue

Edinburgh International Conference Centre (EICC)
The Exchange Edinburgh
Edinburgh EH3 8EE Scotland
United Kingdom

map

Ground Transportation

Housing

There are several hotels within close proximity to the EICC. If you have any questions, please contact our meeting registrar at Vanern Enterprises.

Note: Citizens of certain countries and territories need a visa to enter the United Kingdom. Visa processing times vary from country to country, so please check the UK Government Website and apply for a visa, if necessary, well in advance of your trip.  Also, those traveling from outside of the United Kingdom will need a valid passport to enter.

Eucomed Compliance

MedTech Europe has vetted and deemed the INS Congress compliant with the Eucomed Code of Ethical Business Practice. Event details are posted within the Ethical MedTech conference database on www.ethicalmedtech.eu.

Congress page